AAPL313.44+4.81 (+1.56%) ▲|ABBV255.35-5.73 (-2.19%) ▼|ABT94.61-0.80 (-0.83%) ▼|ACN137.23-0.12 (-0.09%) ▼|ADBE218.47-1.25 (-0.57%) ▼|AMAT600.14-2.90 (-0.48%) ▼|AMD566.53+48.71 (+9.41%) ▲|AMGN363.66-10.49 (-2.80%) ▼|AMT161.73-4.30 (-2.59%) ▼|AMZN245.69+3.02 (+1.24%) ▲|AVGO374.10+13.65 (+3.79%) ▲|AXP356.08+4.12 (+1.17%) ▲|BA232.23+5.74 (+2.53%) ▲|BAC59.49+0.76 (+1.29%) ▲|BKNG183.11-1.46 (-0.79%) ▼|BLK1,000.82+5.09 (+0.51%) ▲|BMY56.54-1.59 (-2.74%) ▼|BNY149.27+2.65 (+1.81%) ▲|BRK-B504.85-2.93 (-0.58%) ▼|C143.11+3.14 (+2.24%) ▲|CAT977.01+13.48 (+1.40%) ▲|CL92.29-2.84 (-2.99%) ▼|CMCSA23.63-0.17 (-0.69%) ▼|COF205.71+0.59 (+0.29%) ▲|COP103.63-1.10 (-1.05%) ▼|COST942.11-9.56 (-1.00%) ▼|CRM166.72+0.61 (+0.36%) ▲|CSCO114.75+2.06 (+1.83%) ▲|CVS102.13-2.59 (-2.47%) ▼|CVX167.53-1.68 (-0.99%) ▼|DE625.12+3.85 (+0.62%) ▲|DHR192.84-5.09 (-2.57%) ▼|DIS97.64-1.87 (-1.87%) ▼|DUK126.70-2.91 (-2.24%) ▼|EMR140.50+1.45 (+1.04%) ▲|FDX309.22-3.78 (-1.21%) ▼|GD374.46+0.92 (+0.25%) ▲|GE378.13+1.08 (+0.29%) ▲|GEV1,154.17+41.06 (+3.69%) ▲|GILD128.76-2.51 (-1.91%) ▼|GM77.37+1.37 (+1.80%) ▲|GOOG361.27+5.09 (+1.43%) ▲|GOOGL363.94+4.03 (+1.12%) ▲|GS1,051.37+30.37 (+2.97%) ▲|HD348.79-9.11 (-2.55%) ▼|HON224.96-4.90 (-2.13%) ▼|IBM299.92+10.40 (+3.59%) ▲|INTC124.32+3.97 (+3.30%) ▲|INTU268.62-6.73 (-2.44%) ▼|ISRG427.92+1.91 (+0.45%) ▲|JNJ257.12-5.92 (-2.25%) ▼|JPM336.01+3.04 (+0.91%) ▲|KO82.47-1.68 (-1.99%) ▼|LIN532.48-14.16 (-2.59%) ▼|LLY1,196.39-17.52 (-1.44%) ▼|LMT536.77-9.14 (-1.67%) ▼|LOW221.85-5.66 (-2.49%) ▼|LRCX358.92+7.51 (+2.14%) ▲|MA529.14-10.26 (-1.90%) ▼|MCD274.96-5.67 (-2.02%) ▼|MDLZ59.06-1.85 (-3.04%) ▼|MDT82.36-0.83 (-1.00%) ▼|META592.58+9.68 (+1.66%) ▲|MMM156.32-4.12 (-2.57%) ▼|MO71.57-1.14 (-1.57%) ▼|MRK126.06-3.50 (-2.70%) ▼|MS221.32+7.39 (+3.45%) ▲|MSFT385.48-5.01 (-1.28%) ▼|MU1,008.37+32.81 (+3.36%) ▲|NEE87.41-0.94 (-1.06%) ▼|NFLX76.33-1.32 (-1.70%) ▼|NKE42.69-1.41 (-3.19%) ▼|NOW108.30+1.98 (+1.86%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.54+2.27 (+1.62%) ▲|PEP141.72-2.50 (-1.73%) ▼|PFE23.78-0.55 (-2.24%) ▼|PG147.23-4.18 (-2.76%) ▼|PLTR133.89+4.59 (+3.55%) ▲|PM182.07-0.20 (-0.11%) ▼|QCOM187.46+11.21 (+6.36%) ▲|RTX199.90+0.65 (+0.33%) ▲|SBUX100.76-3.51 (-3.37%) ▼|SCHW99.28+2.28 (+2.35%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG224.60-1.46 (-0.65%) ▼|T20.49-0.09 (-0.45%) ▼|TMO514.52-8.93 (-1.71%) ▼|TMUS180.91+3.39 (+1.91%) ▲|TSLA414.37+20.92 (+5.32%) ▲|TXN303.09+10.01 (+3.41%) ▲|UBER73.55-0.88 (-1.18%) ▼|UNH415.17-10.20 (-2.40%) ▼|UNP280.28-1.97 (-0.70%) ▼|UPS109.32-1.34 (-1.21%) ▼|USB62.74+1.01 (+1.64%) ▲|V353.83-8.30 (-2.29%) ▼|VZ42.02-0.54 (-1.27%) ▼|WFC87.15+1.64 (+1.92%) ▲|WMT109.40-2.44 (-2.18%) ▼|XOM136.36-0.73 (-0.53%) ▼|AAPL313.44+4.81 (+1.56%) ▲|ABBV255.35-5.73 (-2.19%) ▼|ABT94.61-0.80 (-0.83%) ▼|ACN137.23-0.12 (-0.09%) ▼|ADBE218.47-1.25 (-0.57%) ▼|AMAT600.14-2.90 (-0.48%) ▼|AMD566.53+48.71 (+9.41%) ▲|AMGN363.66-10.49 (-2.80%) ▼|AMT161.73-4.30 (-2.59%) ▼|AMZN245.69+3.02 (+1.24%) ▲|AVGO374.10+13.65 (+3.79%) ▲|AXP356.08+4.12 (+1.17%) ▲|BA232.23+5.74 (+2.53%) ▲|BAC59.49+0.76 (+1.29%) ▲|BKNG183.11-1.46 (-0.79%) ▼|BLK1,000.82+5.09 (+0.51%) ▲|BMY56.54-1.59 (-2.74%) ▼|BNY149.27+2.65 (+1.81%) ▲|BRK-B504.85-2.93 (-0.58%) ▼|C143.11+3.14 (+2.24%) ▲|CAT977.01+13.48 (+1.40%) ▲|CL92.29-2.84 (-2.99%) ▼|CMCSA23.63-0.17 (-0.69%) ▼|COF205.71+0.59 (+0.29%) ▲|COP103.63-1.10 (-1.05%) ▼|COST942.11-9.56 (-1.00%) ▼|CRM166.72+0.61 (+0.36%) ▲|CSCO114.75+2.06 (+1.83%) ▲|CVS102.13-2.59 (-2.47%) ▼|CVX167.53-1.68 (-0.99%) ▼|DE625.12+3.85 (+0.62%) ▲|DHR192.84-5.09 (-2.57%) ▼|DIS97.64-1.87 (-1.87%) ▼|DUK126.70-2.91 (-2.24%) ▼|EMR140.50+1.45 (+1.04%) ▲|FDX309.22-3.78 (-1.21%) ▼|GD374.46+0.92 (+0.25%) ▲|GE378.13+1.08 (+0.29%) ▲|GEV1,154.17+41.06 (+3.69%) ▲|GILD128.76-2.51 (-1.91%) ▼|GM77.37+1.37 (+1.80%) ▲|GOOG361.27+5.09 (+1.43%) ▲|GOOGL363.94+4.03 (+1.12%) ▲|GS1,051.37+30.37 (+2.97%) ▲|HD348.79-9.11 (-2.55%) ▼|HON224.96-4.90 (-2.13%) ▼|IBM299.92+10.40 (+3.59%) ▲|INTC124.32+3.97 (+3.30%) ▲|INTU268.62-6.73 (-2.44%) ▼|ISRG427.92+1.91 (+0.45%) ▲|JNJ257.12-5.92 (-2.25%) ▼|JPM336.01+3.04 (+0.91%) ▲|KO82.47-1.68 (-1.99%) ▼|LIN532.48-14.16 (-2.59%) ▼|LLY1,196.39-17.52 (-1.44%) ▼|LMT536.77-9.14 (-1.67%) ▼|LOW221.85-5.66 (-2.49%) ▼|LRCX358.92+7.51 (+2.14%) ▲|MA529.14-10.26 (-1.90%) ▼|MCD274.96-5.67 (-2.02%) ▼|MDLZ59.06-1.85 (-3.04%) ▼|MDT82.36-0.83 (-1.00%) ▼|META592.58+9.68 (+1.66%) ▲|MMM156.32-4.12 (-2.57%) ▼|MO71.57-1.14 (-1.57%) ▼|MRK126.06-3.50 (-2.70%) ▼|MS221.32+7.39 (+3.45%) ▲|MSFT385.48-5.01 (-1.28%) ▼|MU1,008.37+32.81 (+3.36%) ▲|NEE87.41-0.94 (-1.06%) ▼|NFLX76.33-1.32 (-1.70%) ▼|NKE42.69-1.41 (-3.19%) ▼|NOW108.30+1.98 (+1.86%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.54+2.27 (+1.62%) ▲|PEP141.72-2.50 (-1.73%) ▼|PFE23.78-0.55 (-2.24%) ▼|PG147.23-4.18 (-2.76%) ▼|PLTR133.89+4.59 (+3.55%) ▲|PM182.07-0.20 (-0.11%) ▼|QCOM187.46+11.21 (+6.36%) ▲|RTX199.90+0.65 (+0.33%) ▲|SBUX100.76-3.51 (-3.37%) ▼|SCHW99.28+2.28 (+2.35%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG224.60-1.46 (-0.65%) ▼|T20.49-0.09 (-0.45%) ▼|TMO514.52-8.93 (-1.71%) ▼|TMUS180.91+3.39 (+1.91%) ▲|TSLA414.37+20.92 (+5.32%) ▲|TXN303.09+10.01 (+3.41%) ▲|UBER73.55-0.88 (-1.18%) ▼|UNH415.17-10.20 (-2.40%) ▼|UNP280.28-1.97 (-0.70%) ▼|UPS109.32-1.34 (-1.21%) ▼|USB62.74+1.01 (+1.64%) ▲|V353.83-8.30 (-2.29%) ▼|VZ42.02-0.54 (-1.27%) ▼|WFC87.15+1.64 (+1.92%) ▲|WMT109.40-2.44 (-2.18%) ▼|XOM136.36-0.73 (-0.53%) ▼|
20.7 C
New York
Monday, July 6, 2026

Tag: program

newssourceFORcompanyinformationcontent1releasesmarket

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients...

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

Recurrent Energy Energizes 1,200 MWh Storage Facility in Arizona Ahead of Peak Summer Demand

First of three projects with APS now in operation, delivering flexible capacity to the grid KITCHENER, ON, July 7, 2025 /PRNewswire/ -- Recurrent Energy, a...

Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program

In week 27 of the year 2025, Kaldalón hf. did not purchase any shares under the share buyback program announced on Nasdaq Iceland hf. on 30 June 2025. The buybacks under the program may amount to a maximum of 15,000,000 shares, provided that the total consideration does not exceed ISK 350,000,000. The execution of the program commenced on Tuesday, 1 July 2024, and will remain in effect until either of the aforementioned thresholds (number of shares or total consideration) has been reached, but no later than 31 December 2025.

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB). 

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB). 
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB).

Festi hf.: Buyback program week 27

In week 27 2025, Festi purchased in total 165,000 own shares for total amount of 47,025,000 ISK as follows:

SOMA GOLD ANNOUNCES AGREEMENT TO ACQUIRE THE ESCONDIDA MINE IN ANTIOQUIA, COLOMBIA

Highlights: Fully-permitted gold mine with a rapid potential for scaleLocated within trucking distance of Soma's El Limón millHigh-grade vein system with an average diluted gold...

Share buy-back program

COMPANY ANNOUNCEMENT NO 36/2025 - JULY 7, 2025

Alm. Brand A/S – Weekly report on share buybacks

Alm. Brand A/S share buy-back program

Digital Finance Forum of Global Digital Economy Conference 2025 Grandly Convened at Beijing Banking & Insurance Business Park

BEIJING, July 7, 2025 /PRNewswire/ -- On July 3, the Digital Finance Forum of the Global Digital Economy Conference 2025 was held at the...

First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy

PARIS, July 07, 2025 (GLOBE NEWSWIRE) --  PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been successfully dosed in its Phase I clinical trial (PST-611-CT1) aiming to assess safety and tolerability of its lead program, PST-611, in humans.

Aktietilbagekøb 30 juni – 4 juli 2025

Selskabsmeddelelse 28/2025                                                                    

Lightchain AI Concludes 15 Presale Phases and Launches Bonus Round With Developer Grant Program

SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a blockchain infrastructure project focused on AI-native applications, has completed all 15 presale phases without delays and is now entering its Bonus Round. The project has raised $21 million to date, with tokens continuing to be available at a fixed price of $0.007.

Panduit Wins Asia Responsible Enterprise Award 2025 for Empowering Youth through Skills Development

SINGAPORE, July 7, 2025 /PRNewswire/ -- Panduit Corp has been awarded the prestigious Asia Responsible Enterprise Award (AREA) 2025 under the Social Empowerment category...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgram

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers